PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow PETS
PetMed Express, Inc. (PETS) Altman Z-score
PetMed Express, Inc.'s Altman Z-score for fiscal 2026 is 0.40, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2026 | 0.40 | (2.66) |
| FY2025 | 3.06 | 0.07 |
| FY2024 | 3.00 | (3.32) |
| FY2023 | 6.32 | (2.70) |
| FY2022 | 9.02 | (4.04) |
| FY2021 | 13.06 | (5.04) |
| FY2020 | 18.10 | (0.82) |
| FY2019 | 18.93 | (12.93) |
| FY2018 | 31.86 | 14.23 |
| FY2017 | 17.63 | (18.70) |
How fiscal 2026’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.10) | — | −0.13 | |
| Retained earnings / total assets | 0.11 | — | 0.16 | |
| EBIT / total assets | (0.72) | — | −2.38 | |
| Market value of equity / total liabilities | 0.91 | — | 0.55 | |
| Sales / total assets | 2.20 | — | 2.20 | |
| Altman Z-score | Distress zone | 0.40 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −4.59 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| SCNX Scienture Holdings, Inc. compare | 5.4× |
| HITI High Tide Inc. compare | 1.5× |
| RDGT Ridgetech Inc. compare | 1.2× |
| PETS PetMed Express, Inc. | 0.4× |
| BIMI BIMI Holdings Inc. compare | −3.8× |
| MDVLQ MedAvail Holdings, Inc. compare | −11.8× |
| MEDS DataMeds AI, Inc compare | −15.2× |
| POM Pomdoctor Limited - Sponsored ADR compare | −33.3× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets